Literature DB >> 23932591

Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Ronnie Per-Arne Berntsson1, Lisheng Peng, Linda Marie Svensson, Min Dong, Pål Stenmark.   

Abstract

Botulinum neurotoxins (BoNTs) can cause paralysis at exceptionally low concentrations and include seven serotypes (BoNT/A-G). The chimeric BoNT/DC toxin has a receptor binding domain similar to the same region in BoNT/C. However, BoNT/DC does not share protein receptor with BoNT/C. Instead, it shares synaptotagmin (Syt) I and II as receptors with BoNT/B, despite their low sequence similarity. Here, we present the crystal structures of the binding domain of BoNT/DC in complex with the recognition domains of its protein receptors, Syt-I and Syt-II. The structures reveal that BoNT/DC possesses a Syt binding site, distinct from the established Syt-II binding site in BoNT/B. Structure-based mutagenesis further shows that hydrophobic interactions play a key role in Syt binding. The structures suggest that the BoNT/DC ganglioside binding sites are independent of the protein receptor binding site. Our results reveal the remarkable versatility in the receptor recognition of the BoNTs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23932591      PMCID: PMC3803103          DOI: 10.1016/j.str.2013.06.026

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  52 in total

Review 1.  Botulinum neurotoxin: a marvel of protein design.

Authors:  Mauricio Montal
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.

Authors:  Kentaro Tsukamoto; Tomoko Kohda; Masafumi Mukamoto; Kumiko Takeuchi; Hideshi Ihara; Masaki Saito; Shunji Kozaki
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.

Authors:  Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

Review 5.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

6.  Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.

Authors:  Lisheng Peng; Ronnie P-A Berntsson; William H Tepp; Rose M Pitkin; Eric A Johnson; Pål Stenmark; Min Dong
Journal:  J Cell Sci       Date:  2012-03-27       Impact factor: 5.285

7.  Structural basis of cell surface receptor recognition by botulinum neurotoxin B.

Authors:  Qing Chai; Joseph W Arndt; Min Dong; William H Tepp; Eric A Johnson; Edwin R Chapman; Raymond C Stevens
Journal:  Nature       Date:  2006-12-13       Impact factor: 49.962

8.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

9.  The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane.

Authors:  Lucia Muraro; Silvio Tosatto; Lisa Motterlini; Ornella Rossetto; Cesare Montecucco
Journal:  Biochem Biophys Res Commun       Date:  2009-01-20       Impact factor: 3.575

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  17 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 2.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

Review 3.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

4.  Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.

Authors:  Jasmin Strotmeier; Stefan Mahrhold; Nadja Krez; Constantin Janzen; Jianlong Lou; James D Marks; Thomas Binz; Andreas Rummel
Journal:  FEBS Lett       Date:  2014-02-25       Impact factor: 4.124

5.  Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C.

Authors:  Roger M Benoit; Martin A Schärer; Mara M Wieser; Xiaodan Li; Daniel Frey; Richard A Kammerer
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

6.  Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.

Authors:  Guorui Yao; Kwok-Ho Lam; Kay Perry; Jasmin Weisemann; Andreas Rummel; Rongsheng Jin
Journal:  Toxins (Basel)       Date:  2017-03-08       Impact factor: 4.546

7.  Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.

Authors:  Jasmin Weisemann; Daniel Stern; Stefan Mahrhold; Brigitte G Dorner; Andreas Rummel
Journal:  Toxins (Basel)       Date:  2016-05-17       Impact factor: 4.546

8.  Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors.

Authors:  Liang Tao; Lisheng Peng; Ronnie P-A Berntsson; Sai Man Liu; SunHyun Park; Feifan Yu; Christopher Boone; Shilpa Palan; Matthew Beard; Pierre-Etienne Chabrier; Pål Stenmark; Johannes Krupp; Min Dong
Journal:  Nat Commun       Date:  2017-07-03       Impact factor: 14.919

9.  A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency.

Authors:  Daniel Stern; Jasmin Weisemann; Alexander Le Blanc; Laura von Berg; Stefan Mahrhold; Janett Piesker; Michael Laue; Peter B Luppa; Martin Bernhard Dorner; Brigitte Gertrud Dorner; Andreas Rummel
Journal:  PLoS Pathog       Date:  2018-05-02       Impact factor: 6.823

10.  Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.

Authors:  Robert Gustafsson; Sicai Zhang; Geoffrey Masuyer; Min Dong; Pål Stenmark
Journal:  Toxins (Basel)       Date:  2018-04-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.